Second and third trimesters of pregnancy.
Biliary obstructive disorders.
Severe hepatic impairment.
Concomitant use with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR <60 mL/min/1.73m2).
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                        
                
                                    
                                            
 Sign Out